PDB Short entry for 1UA7 HEADER HYDROLASE 03-MAR-03 1UA7 TITLE CRYSTAL STRUCTURE ANALYSIS OF ALPHA-AMYLASE FROM BACILLUS SUBTILIS TITLE 2 COMPLEXED WITH ACARBOSE COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALPHA-AMYLASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 4-425; COMPND 5 SYNONYM: ALPHA-1,4-GLUCAN-4-GLUCANOHYDROLASE; COMPND 6 EC: 3.2.1.1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BACILLUS SUBTILIS; SOURCE 3 ORGANISM_TAXID: 1423; SOURCE 4 EXPRESSION_SYSTEM: BACILLUS SUBTILIS; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 1423; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: 207-25; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PNQ356 KEYWDS BETA-ALPHA-BARRELS, ACARBOSE, GREEK-KEY MOTIF, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR M.KAGAWA,Z.FUJIMOTO,M.MOMMA,K.TAKASE,H.MIZUNO REVDAT 7 27-DEC-23 1UA7 1 REMARK REVDAT 6 10-NOV-21 1UA7 1 SEQADV HETSYN REVDAT 5 29-JUL-20 1UA7 1 COMPND REMARK HETNAM LINK REVDAT 5 2 1 SITE ATOM REVDAT 4 25-OCT-17 1UA7 1 HETSYN LINK ATOM REVDAT 3 04-OCT-17 1UA7 1 REMARK REVDAT 2 24-FEB-09 1UA7 1 VERSN REVDAT 1 18-MAY-04 1UA7 0 JRNL AUTH M.KAGAWA,Z.FUJIMOTO,M.MOMMA,K.TAKASE,H.MIZUNO JRNL TITL CRYSTAL STRUCTURE OF BACILLUS SUBTILIS ALPHA-AMYLASE IN JRNL TITL 2 COMPLEX WITH ACARBOSE JRNL REF J.BACTERIOL. V. 185 6981 2003 JRNL REFN ISSN 0021-9193 JRNL PMID 14617662 JRNL DOI 10.1128/JB.185.23.6981-6984.2003 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH Z.FUJIMOTO,K.TAKASE,N.DOUI,M.MOMMA,T.MATSUMOTO,H.MIZUNO REMARK 1 TITL CRYSTAL STRUCTURE OF A CATALYTIC-SITE MUTANT ALPHA-AMYLASE REMARK 1 TITL 2 FROM BACILLUS SUBTILIS COMPLEXED WITH MALTOPENTAOSE REMARK 1 REF J.MOL.BIOL. V. 277 393 1998 REMARK 1 REFN ISSN 0022-2836 REMARK 1 DOI 10.1006/JMBI.1997.1599 REMARK 1 REFERENCE 2 REMARK 1 AUTH H.MIZUNO,Y.MORIMOTO,T.TSUKIHARA,T.MATSUMOTO,K.TAKASE REMARK 1 TITL CRYSTALLIZATION AND PRELIMINARY X-RAY STUDIES OF WILD TYPE REMARK 1 TITL 2 AND CATALYTIC-SITE MUTANT ALPHA-AMYLASE FROM BACILLUS REMARK 1 TITL 3 SUBTILIS REMARK 1 REF J.MOL.BIOL. V. 234 1282 1993 REMARK 1 REFN ISSN 0022-2836 REMARK 1 DOI 10.1006/JMBI.1993.1683 REMARK 1 REFERENCE 3 REMARK 1 AUTH K.TAKASE,T.MATSUMOTO,H.MIZUNO,K.YAMANE REMARK 1 TITL SITE-DIRECTED MUTAGENESIS OF ACTIVE SITE RESIDUES IN REMARK 1 TITL 2 BACILLUS SUBTILIS ALPHA-AMYLASE REMARK 1 REF BIOCHIM.BIOPHYS.ACTA V.1120 281 1992 REMARK 1 REFN ISSN 0006-3002 REMARK 1 DOI 10.1016/0167-4838(92)90249-D REMARK 1 REFERENCE 4 REMARK 1 AUTH K.YAMANE,Y.HIRATA,T.FURUSATO,H.YAMAZAKI,A.NAKAYAMA REMARK 1 TITL CHANGES IN THE PROPERTIES AND MOLECULAR WEIGHTS OF BACILLUS REMARK 1 TITL 2 SUBTILIS M-TYPE AND N-TYPE ALPHA-AMYLASES RESULTING FROM A REMARK 1 TITL 3 SPONTANEOUS DELETION REMARK 1 REF J.BIOCHEM.(TOKYO) V. 96 1849 1984 REMARK 1 REFN ISSN 0021-924X REMARK 2 REMARK 2 RESOLUTION. 2.21 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.21 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.97 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.5 REMARK 3 NUMBER OF REFLECTIONS : 29744 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.208 REMARK 3 FREE R VALUE : 0.265 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2974 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.34 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 85.70 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3991 REMARK 3 BIN R VALUE (WORKING SET) : 0.2830 REMARK 3 BIN FREE R VALUE : 0.3370 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 9.90 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 440 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.016 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3303 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 68 REMARK 3 SOLVENT ATOMS : 437 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 6.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 10.47000 REMARK 3 B22 (A**2) : -4.11000 REMARK 3 B33 (A**2) : -6.36000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.26 REMARK 3 ESD FROM SIGMAA (A) : 0.30 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.35 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.37 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.200 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.90 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.730 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.35 REMARK 3 BSOL : 56.56 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : XDICT_22141MOD.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1UA7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 10-MAR-03. REMARK 100 THE DEPOSITION ID IS D_1000005609. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-FEB-01 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU ULTRAX 18 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : R-AXIS REMARK 200 DATA SCALING SOFTWARE : R-AXIS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 31194 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 45.490 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.7 REMARK 200 DATA REDUNDANCY : 3.460 REMARK 200 R MERGE (I) : 0.09700 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 22.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.7 REMARK 200 DATA REDUNDANCY IN SHELL : 3.40 REMARK 200 R MERGE FOR SHELL (I) : 0.23900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 7.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.22 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.83 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 3350, CALCIUM CHLORIDE, TRIS-HCL, REMARK 280 ACARBOSE, PH 7.2, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 293.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 35.16000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 57.86200 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.10200 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 57.86200 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 35.16000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.10200 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 142 18.12 57.88 REMARK 500 LEU A 244 34.03 -96.34 REMARK 500 ASP A 259 -7.12 -56.58 REMARK 500 TYR A 423 145.63 178.56 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 603 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLU A 89 OE2 REMARK 620 2 GLU A 276 OE2 72.3 REMARK 620 3 GLU A 276 OE1 123.0 52.8 REMARK 620 4 GLY A 313 O 96.1 108.2 88.0 REMARK 620 5 HOH A 795 O 80.0 148.9 157.0 88.1 REMARK 620 6 HOH A 811 O 96.8 81.5 90.0 165.8 88.3 REMARK 620 7 HOH A 905 O 155.9 131.7 80.7 78.9 76.3 86.8 REMARK 620 N 1 2 3 4 5 6 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 601 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASN A 101 OD1 REMARK 620 2 THR A 137 O 155.5 REMARK 620 3 ASP A 146 OD1 72.2 119.6 REMARK 620 4 ASP A 146 OD2 120.1 79.2 50.1 REMARK 620 5 HIS A 180 O 73.0 85.0 134.5 161.6 REMARK 620 6 HOH A 608 O 66.3 136.3 71.5 79.9 118.4 REMARK 620 7 HOH A 667 O 113.4 75.6 132.8 97.3 87.9 69.5 REMARK 620 8 HOH A 798 O 91.4 74.2 71.7 85.6 80.9 141.2 148.6 REMARK 620 N 1 2 3 4 5 6 7 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 602 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLY A 169 O REMARK 620 2 ASP A 171 OD2 92.5 REMARK 620 3 ASP A 171 OD1 102.0 55.9 REMARK 620 4 HOH A 716 O 102.3 76.4 126.7 REMARK 620 5 HOH A 796 O 172.0 88.2 85.0 70.1 REMARK 620 6 HOH A 800 O 94.7 151.4 147.5 75.0 81.0 REMARK 620 7 HOH A 801 O 88.0 134.6 79.7 147.3 97.2 73.3 REMARK 620 N 1 2 3 4 5 6 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1BAG RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH MALTOPENTAOSE DBREF 1UA7 A 4 425 UNP P00691 AMY_BACSU 45 466 SEQADV 1UA7 PHE A 105 UNP P00691 SER 146 SEE REMARK 999 SEQADV 1UA7 GLU A 163 UNP P00691 ASP 204 SEE REMARK 999 SEQADV 1UA7 GLN A 356 UNP P00691 ASN 397 ENGINEERED MUTATION SEQRES 1 A 422 PRO SER ILE LYS SER GLY THR ILE LEU HIS ALA TRP ASN SEQRES 2 A 422 TRP SER PHE ASN THR LEU LYS HIS ASN MET LYS ASP ILE SEQRES 3 A 422 HIS ASP ALA GLY TYR THR ALA ILE GLN THR SER PRO ILE SEQRES 4 A 422 ASN GLN VAL LYS GLU GLY ASN GLN GLY ASP LYS SER MET SEQRES 5 A 422 SER ASN TRP TYR TRP LEU TYR GLN PRO THR SER TYR GLN SEQRES 6 A 422 ILE GLY ASN ARG TYR LEU GLY THR GLU GLN GLU PHE LYS SEQRES 7 A 422 GLU MET CYS ALA ALA ALA GLU GLU TYR GLY ILE LYS VAL SEQRES 8 A 422 ILE VAL ASP ALA VAL ILE ASN HIS THR THR PHE ASP TYR SEQRES 9 A 422 ALA ALA ILE SER ASN GLU VAL LYS SER ILE PRO ASN TRP SEQRES 10 A 422 THR HIS GLY ASN THR GLN ILE LYS ASN TRP SER ASP ARG SEQRES 11 A 422 TRP ASP VAL THR GLN ASN SER LEU LEU GLY LEU TYR ASP SEQRES 12 A 422 TRP ASN THR GLN ASN THR GLN VAL GLN SER TYR LEU LYS SEQRES 13 A 422 ARG PHE LEU GLU ARG ALA LEU ASN ASP GLY ALA ASP GLY SEQRES 14 A 422 PHE ARG PHE ASP ALA ALA LYS HIS ILE GLU LEU PRO ASP SEQRES 15 A 422 ASP GLY SER TYR GLY SER GLN PHE TRP PRO ASN ILE THR SEQRES 16 A 422 ASN THR SER ALA GLU PHE GLN TYR GLY GLU ILE LEU GLN SEQRES 17 A 422 ASP SER ALA SER ARG ASP ALA ALA TYR ALA ASN TYR MET SEQRES 18 A 422 ASP VAL THR ALA SER ASN TYR GLY HIS SER ILE ARG SER SEQRES 19 A 422 ALA LEU LYS ASN ARG ASN LEU GLY VAL SER ASN ILE SER SEQRES 20 A 422 HIS TYR ALA SER ASP VAL SER ALA ASP LYS LEU VAL THR SEQRES 21 A 422 TRP VAL GLU SER HIS ASP THR TYR ALA ASN ASP ASP GLU SEQRES 22 A 422 GLU SER THR TRP MET SER ASP ASP ASP ILE ARG LEU GLY SEQRES 23 A 422 TRP ALA VAL ILE ALA SER ARG SER GLY SER THR PRO LEU SEQRES 24 A 422 PHE PHE SER ARG PRO GLU GLY GLY GLY ASN GLY VAL ARG SEQRES 25 A 422 PHE PRO GLY LYS SER GLN ILE GLY ASP ARG GLY SER ALA SEQRES 26 A 422 LEU PHE GLU ASP GLN ALA ILE THR ALA VAL ASN ARG PHE SEQRES 27 A 422 HIS ASN VAL MET ALA GLY GLN PRO GLU GLU LEU SER ASN SEQRES 28 A 422 PRO GLN GLY ASN ASN GLN ILE PHE MET ASN GLN ARG GLY SEQRES 29 A 422 SER HIS GLY VAL VAL LEU ALA ASN ALA GLY SER SER SER SEQRES 30 A 422 VAL SER ILE ASN THR ALA THR LYS LEU PRO ASP GLY ARG SEQRES 31 A 422 TYR ASP ASN LYS ALA GLY ALA GLY SER PHE GLN VAL ASN SEQRES 32 A 422 ASP GLY LYS LEU THR GLY THR ILE ASN ALA ARG SER VAL SEQRES 33 A 422 ALA VAL LEU TYR PRO ASP HET GLC B 1 12 HET GLD B 2 9 HET BGC C 1 12 HET G6D C 2 9 HET ACI A 501 12 HET ACI A 504 11 HET CA A 601 1 HET CA A 602 1 HET CA A 603 1 HETNAM GLC ALPHA-D-GLUCOPYRANOSE HETNAM GLD 4,6-DIDEOXY-ALPHA-D-XYLO-HEXOPYRANOSE HETNAM BGC BETA-D-GLUCOPYRANOSE HETNAM G6D ALPHA-D-QUINOVOPYRANOSE HETNAM ACI 6-AMINO-4-HYDROXYMETHYL-CYCLOHEX-4-ENE-1,2,3-TRIOL HETNAM CA CALCIUM ION HETSYN GLC ALPHA-D-GLUCOSE; D-GLUCOSE; GLUCOSE HETSYN GLD 4,6-DIDEOXYGLUCOSE; 4,6-DIDEOXY-ALPHA-D-XYLO-HEXOSE; 4, HETSYN 2 GLD 6-DIDEOXY-D-XYLO-HEXOSE; 4,6-DIDEOXY-XYLO-HEXOSE HETSYN BGC BETA-D-GLUCOSE; D-GLUCOSE; GLUCOSE HETSYN G6D ALPHA-D-QUINOVOSE; 6-DEOXY-ALPHA-D-GLUCOPYRANOSE; D- HETSYN 2 G6D QUINOVOSE; QUINOVOSE; 6-DEOXY-ALPHA-D-GLUCOSE FORMUL 2 GLC C6 H12 O6 FORMUL 2 GLD C6 H12 O4 FORMUL 3 BGC C6 H12 O6 FORMUL 3 G6D C6 H12 O5 FORMUL 4 ACI 2(C7 H13 N O4) FORMUL 6 CA 3(CA 2+) FORMUL 9 HOH *437(H2 O) HELIX 1 1 SER A 18 ASN A 25 1 8 HELIX 2 2 ASN A 25 ALA A 32 1 8 HELIX 3 3 GLY A 48 ASP A 52 5 5 HELIX 4 4 SER A 54 TYR A 62 5 9 HELIX 5 5 GLU A 77 GLU A 89 1 13 HELIX 6 6 SER A 111 SER A 116 1 6 HELIX 7 7 ASP A 132 ASN A 139 1 8 HELIX 8 8 ASN A 151 ASP A 168 1 18 HELIX 9 9 ALA A 177 ILE A 181 5 5 HELIX 10 10 ASP A 186 GLY A 190 5 5 HELIX 11 11 GLN A 192 THR A 198 1 7 HELIX 12 12 ARG A 216 ASN A 222 1 7 HELIX 13 13 ALA A 228 ARG A 242 1 15 HELIX 14 14 GLY A 245 SER A 250 1 6 HELIX 15 15 SER A 257 ASP A 259 5 3 HELIX 16 16 SER A 267 ASN A 273 1 7 HELIX 17 17 SER A 282 SER A 295 1 14 HELIX 18 18 SER A 327 GLU A 331 5 5 HELIX 19 19 ASP A 332 ALA A 346 1 15 HELIX 20 20 ASN A 354 ASN A 358 5 5 SHEET 1 A 9 ILE A 11 HIS A 13 0 SHEET 2 A 9 ALA A 36 THR A 39 1 O GLN A 38 N LEU A 12 SHEET 3 A 9 LYS A 93 ALA A 98 1 O ILE A 95 N ILE A 37 SHEET 4 A 9 GLY A 172 PHE A 175 1 O GLY A 172 N VAL A 96 SHEET 5 A 9 PHE A 204 GLY A 207 1 O TYR A 206 N PHE A 175 SHEET 6 A 9 ASP A 225 THR A 227 1 O ASP A 225 N GLY A 207 SHEET 7 A 9 LEU A 261 THR A 263 1 O VAL A 262 N VAL A 226 SHEET 8 A 9 THR A 300 PHE A 304 1 O LEU A 302 N THR A 263 SHEET 9 A 9 ILE A 11 HIS A 13 1 N HIS A 13 O PHE A 303 SHEET 1 B 3 ASN A 43 VAL A 45 0 SHEET 2 B 3 PRO A 64 ASN A 71 -1 O THR A 65 N GLN A 44 SHEET 3 B 3 GLY A 75 THR A 76 -1 O GLY A 75 N ASN A 71 SHEET 1 C 2 THR A 121 GLY A 123 0 SHEET 2 C 2 ASP A 146 TRP A 147 -1 O ASP A 146 N GLY A 123 SHEET 1 D 4 LEU A 352 SER A 353 0 SHEET 2 D 4 ILE A 361 ARG A 366 -1 O MET A 363 N SER A 353 SHEET 3 D 4 GLY A 370 ASN A 375 -1 O ALA A 374 N PHE A 362 SHEET 4 D 4 SER A 418 LEU A 422 -1 O SER A 418 N ASN A 375 SHEET 1 E 4 VAL A 381 ALA A 386 0 SHEET 2 E 4 LYS A 409 ILE A 414 -1 O LEU A 410 N THR A 385 SHEET 3 E 4 SER A 402 ASN A 406 -1 N GLN A 404 O THR A 411 SHEET 4 E 4 GLY A 392 ASP A 395 -1 N GLY A 392 O VAL A 405 LINK N1 ACI A 501 C4 GLD B 2 1555 1555 1.47 LINK C4 ACI A 504 O1 GLC B 1 1555 1555 1.45 LINK N1 ACI A 504 C4 G6D C 2 1555 1555 1.49 LINK O4 GLC B 1 C1 GLD B 2 1555 1555 1.43 LINK O4 BGC C 1 C1 G6D C 2 1555 1555 1.44 LINK OE2 GLU A 89 CA CA A 603 3555 1555 2.55 LINK OD1 ASN A 101 CA CA A 601 1555 1555 2.54 LINK O THR A 137 CA CA A 601 1555 1555 2.43 LINK OD1 ASP A 146 CA CA A 601 1555 1555 2.55 LINK OD2 ASP A 146 CA CA A 601 1555 1555 2.62 LINK O GLY A 169 CA CA A 602 1555 1555 2.30 LINK OD2 ASP A 171 CA CA A 602 1555 1555 2.33 LINK OD1 ASP A 171 CA CA A 602 1555 1555 2.34 LINK O HIS A 180 CA CA A 601 1555 1555 2.20 LINK OE2 GLU A 276 CA CA A 603 1555 1555 2.41 LINK OE1 GLU A 276 CA CA A 603 1555 1555 2.52 LINK O GLY A 313 CA CA A 603 1555 1555 2.30 LINK CA CA A 601 O HOH A 608 1555 1555 2.38 LINK CA CA A 601 O HOH A 667 1555 1555 2.31 LINK CA CA A 601 O HOH A 798 1555 1555 2.47 LINK CA CA A 602 O HOH A 716 1555 1555 2.63 LINK CA CA A 602 O HOH A 796 1555 1555 2.43 LINK CA CA A 602 O HOH A 800 1555 1555 2.41 LINK CA CA A 602 O HOH A 801 1555 1555 2.45 LINK CA CA A 603 O HOH A 795 1555 1555 2.39 LINK CA CA A 603 O HOH A 811 1555 1555 2.50 LINK CA CA A 603 O HOH A 905 1555 1555 2.29 CRYST1 70.320 74.204 115.724 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014221 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013476 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008641 0.00000